Muller M J, Prior T, Hunt R H, Rangachari P K
Intestinal Disease Research Programme, McMaster University Medical Center, Hamilton, Ont., Canada.
Eur J Pharmacol. 1994 Jan 14;251(2-3):151-6. doi: 10.1016/0014-2999(94)90395-6.
In vitro contractility studies were conducted in canine gastric muscularis mucosae muscle strips with the adenosine analogues 2-chloroadenosine (CIAD), 5'-N-ethylcarboxamidoadenosine (NECA), 5'-(N-cyclopropyl)-carboxamidoadenosine (CPCA), R-N6-(2-phenylisopropyl)adenosine (R-PIA), S-PIA, N6-cyclohexyladenosine (CHA) and (2-p-carboxyethyl)phenylamino-5'-N-carboxamidoadenosine (CGS21680) as well as the A1-selective antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX). Adenosine analogues contracted the muscle strips with the following rank order of potency: CPCA > NECA > CIAD > R-PIA > CHA > S-PIA > CGS21680. CPCA, R-PIA, and CHA were partial agonists. At a concentration selective for adenosine A1 receptors (50 nM), DPCPX did not alter the concentration-response curves to CIAD or CHA. However, at higher concentrations (1-10 microM), DPCPX antagonized CIAD-mediated contractions in a competitive manner (pA2 = 6.96; slope = 0.93). CIAD-mediated contraction was not altered by treatment of the muscle strips with tetrodotoxin (1 microgram/ml) or mepyramine (1 microM). Our results indicate that adenosine A1 receptors, nerves or mast cells are not involved in contraction of canine gastric muscularis mucosae by adenosine analogues.
利用腺苷类似物2-氯腺苷(CIAD)、5'-N-乙基羧酰胺腺苷(NECA)、5'-(N-环丙基)-羧酰胺腺苷(CPCA)、R-N6-(2-苯异丙基)腺苷(R-PIA)、S-PIA、N6-环己基腺苷(CHA)和(2-对羧乙基)苯氨基-5'-N-羧酰胺腺苷(CGS21680)以及A1选择性拮抗剂1,3-二丙基-8-环戊基黄嘌呤(DPCPX),对犬胃黏膜肌条进行了体外收缩性研究。腺苷类似物使肌条收缩,其效力顺序如下:CPCA > NECA > CIAD > R-PIA > CHA > S-PIA > CGS21680。CPCA、R-PIA和CHA为部分激动剂。在对腺苷A1受体有选择性的浓度(50 nM)下,DPCPX并未改变对CIAD或CHA的浓度-反应曲线。然而,在更高浓度(1-10 μM)下,DPCPX以竞争性方式拮抗CIAD介导的收缩(pA2 = 6.96;斜率 = 0.93)。用河豚毒素(1 μg/ml)或美吡拉敏(1 μM)处理肌条后,CIAD介导的收缩未改变。我们的结果表明,腺苷A1受体、神经或肥大细胞不参与腺苷类似物引起的犬胃黏膜肌收缩。